Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Marker Therapeutics Inc (MRKR)
NASDAQ:MRKR
Marker Therapeutics (MRKR) Stock Price & Analysis
479 Followers
MRKR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.76 - $9.68
Previous Close$4.4
Volume5.64K
Average Volume (3M)20.06K
Market Cap
$38.81M
Enterprise Value$24.43M
Total Cash (Recent Filing)$15.10M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-2.3
Beta0.70
Next Earnings
May 09, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.93
Shares Outstanding8,902,897
10 Day Avg. Volume23,404
30 Day Avg. Volume20,062
Standard Deviation0.32
R-Squared0.06
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)2.81
Price to Sales (P/S)11.83
Price to Cash Flow (P/CF)-4.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.76
Enterprise Value/Gross Profit7.38
Enterprise Value/Ebitda-1.89
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Marker Therapeutics News
PremiumCompany Announcements
Marker Therapeutics’ MT-601 Shows Promising Results
PremiumCompany Announcements
Marker Therapeutics Advances in Immuno-Oncology
PremiumCompany Announcements
Marker Therapeutics Ends Stock Sale Deal with LPCRisk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MRKR FAQ
What was Marker Therapeutics Inc’s price range in the past 12 months?
Marker Therapeutics Inc lowest stock price was $0.76 and its highest was $9.68 in the past 12 months.
What is Marker Therapeutics Inc’s market cap?
Currently, no data Available
When is Marker Therapeutics Inc’s upcoming earnings report date?
Marker Therapeutics Inc’s upcoming earnings report date is May 09, 2024 which is in 16 days.
How were Marker Therapeutics Inc’s earnings last quarter?
Marker Therapeutics Inc released its earnings results on Mar 25, 2024. The company reported -$0.308 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.308.
Is Marker Therapeutics Inc overvalued?
According to Wall Street analysts Marker Therapeutics Inc’s price is currently Overvalued.
Does Marker Therapeutics Inc pay dividends?
Marker Therapeutics Inc does not currently pay dividends.
What is Marker Therapeutics Inc’s EPS estimate?
Marker Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Marker Therapeutics Inc have?
Marker Therapeutics Inc has 8,902,897 shares outstanding.
What happened to Marker Therapeutics Inc’s price movement after its last earnings report?
Marker Therapeutics Inc reported an EPS of -$0.308 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -10.744%.
Which hedge fund is a major shareholder of Marker Therapeutics Inc?
Among the largest hedge funds holding Marker Therapeutics Inc’s share is Aisling Capital Management LP. It holds Marker Therapeutics Inc’s shares valued at 2M.
---
Marker Therapeutics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
300.00%
12-Months-Change
Fundamentals
Return on Equity
-87.89%
Trailing 12-Months
Asset Growth
-50.24%
Trailing 12-Months
Company Description
Marker Therapeutics Inc
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which specializes in the development and commercialization of novel cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.
---
Technical Analysis
---